Qualaquin

Qualaquin is a brand name of quinine, approved by the FDA in the following formulation(s):

QUALAQUIN (quinine sulfate - capsule; oral)

• 
  Manufacturer: AR HOLDING CO INC
  
  Approval date: August 12, 2005
  
  Strength(s): 324MG ^[RLD]

Has a generic version of Qualaquin been approved?

No. There is currently no therapeutically equivalent version of Qualaquin available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Qualaquin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Qualaquin.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • August 12, 2012 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• Qualaquin Consumer Information (Wolters Kluwer)
• Qualaquin Consumer Information (Cerner Multum)
• Qualaquin Advanced Consumer Information (Micromedex)
• Quinine Consumer Information (Wolters Kluwer)
• Quinine Capsules Consumer Information (Wolters Kluwer)
• Quinine Consumer Information (Cerner Multum)
• Quinamm Advanced Consumer Information (Micromedex)
• Quiphile Advanced Consumer Information (Micromedex)
• Quinine Advanced Consumer Information (Micromedex)
• Quinine Sulfate AHFS DI Monographs (ASHP)